Ian Johnston

Cleveland Clinic — United States

Medicine · Health Sciences

43h-index11.3kcitations168works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cerebral Venous Sinus Thrombosis(20), CAR-T cell therapy research(17), SARS-CoV-2 and COVID-19 Research(16), Virus-based gene therapy research(16), Cerebrospinal fluid and hydrocephalus(13)

Publications158 total

0644 Antiseptic treatment improves response to topical imiquimod therapy in a UVB-induced non-melanoma skin cancer murine model
Journal of Investigative Dermatology·2025
LB1220 The role of the microbiome in topical treatment efficacy for non-melanoma skin cancer in a UV-induced non-melanoma skin cancer mouse model
Journal of Investigative Dermatology·2025
Navigating the RNA Lipid Nanoparticle Landscape
Genetic Engineering & Biotechnology News·2024
817 Topical PALA has greater therapeutic efficacy and fewer side effects than standards of care in a UV-induced non-melanoma skin cancer mouse model
Journal of Investigative Dermatology·2024Open Access
RVI-seq - Multi-respiratory virus sequencing protocol v1
2024· 1 citedOpen Access
Ganglioside SSEA-4 in Ewing sarcoma marks a tumor cell population with aggressive features and is a potential cell-surface immune target
Scientific Reports·2024· 4 citedOpen Access
0893 Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans with Comorbid Chronic Obstructive
SLEEP·2024Open Access
0467 Effect of Hypoxia on Ventilatory Responsiveness in Opioid-Related Sleep Disordered Breathing
SLEEP·2024Open Access
Automated manufacture of ΔNPM1 TCR-engineered T cells for AML therapy
Molecular Therapy — Methods & Clinical Development·2024· 4 citedOpen Access
A call to adapt the regulation of HLA testing for T cell receptor-based therapeutics
Nature Reviews Drug Discovery·2023· 5 cited
VI On Prognosis from the Pulses (De praesagitione ex pulsibus, libri IV IX.205–430K)
2023
Generation of Antibodies Selectively Recognizing Epitopes in a Formaldehyde-Fixed Cell-Surface Antigen Using Virus-like Particle Display and Hybridoma Technology
Antibodies·2023· 3 citedOpen Access
Targeting Stage-Specific Embryonic Antigen 4 (SSEA-4) in Triple Negative Breast Cancer by CAR T Cells Results in Unexpected on Target/off Tumor Toxicities in Mice
International Journal of Molecular Sciences·2023· 10 citedOpen Access
Immunotherapy: WORKFLOW TO ANALYZE AND THEREBY OPTIMIZE A STANDARDIZED MANUFACTURING PROCESS FOR CAR T CELLS TOWARDS IMPROVED CRITICAL QUALITY ATTRIBUTES OF THE FINAL CAR T CELL PRODUCT
Cytotherapy·2023
Abstract 4068: Ganglioside SSEA4 in Ewing sarcoma: A marker of tumor cells with highly aggressive features and a potential immune target
Cancer Research·2023· 1 cited
Data from Specific Elimination of CD133<sup>+</sup> Tumor Cells with Targeted Oncolytic Measles Virus
2023Open Access
Supplementary Figures 1-8 from Specific Elimination of CD133<sup>+</sup> Tumor Cells with Targeted Oncolytic Measles Virus
2023Open Access
Supplementary Figures 1-8 from Specific Elimination of CD133<sup>+</sup> Tumor Cells with Targeted Oncolytic Measles Virus
2023Open Access
Data from Specific Elimination of CD133<sup>+</sup> Tumor Cells with Targeted Oncolytic Measles Virus
2023Open Access
Investigation of hospital discharge cases and SARS-CoV-2 introduction into Lothian care homes
Journal of Hospital Infection·2023· 2 citedOpen Access
page 1 of 8Next →

Frequent Co-authors

Michael Besser(6), Volker ter Meulen(5), David K. Jackson(4), Sónia Gonçalves(4), John Sillitoe(4), Cristina V. Ariani(4), Roberto Amato(3), Dominic Kwiatkowski(3), Alex Alderton(3), Andrew D. Paterson(3), Vincent Hayes(3), Gowthami M. Arepally(3), Douglas B. Cines(3), Lubica Rauova(3), Mortimer Poncz(3), Sibylle Schneider‐Schaulies(3), Christian J. Buchholz(3), Michael K. Morgan(3), Jeffrey C. Barrett(3), M. Estée Török(2)